... (USFDA) for marketing the 250 mg, 500 mg, 750 mg tablets of Levofloxacin, which is used for the treatment in a broad spectrum of bacterial infections. ...
Levofloxacin is the generic name for the brand Levaquin, marketed in the United States by Ortho Mcneil (Johnson & Johnson). Wockhardt will launch the ...
Wockhardt has received tentative approval from the FDA for marketing the 250mg, 500mg and 750mg tablets of levofloxacin, which is used for treatment in a ...
All patients received tetanus prophylaxis and empiric systemic antibiotics (vancomycin and levofloxacin). Advanced Trauma Life Support protocol was employed ...
... late Wednesday it has received a tentative approval from the US Food & Drug Administration for marketing various doses of anti-bacterial Levofloxacin. ...
Journal of the American Podiatric Medical Association (subscription) - Jan 21, 2010
92 – 95 Levofloxacin and moxifloxacin have better gram-positive coverage than does ciprofloxacin and are, therefore, more appropriate for complicated skin ...
Also known as levofloxacin, Levaquin is in the fluoroquinolone drug class, which is a broad class of widely-used antibiotics. The oral medication can and ...
Wockhardt rose 2.63%, after the company received tentative approval from the US Food & Drug Administration for marketing Levofloxacin tablets in multiple ...
As per a leading business daily, Mumbai based pharma major Wockhardt has won USFDA's tentative approval to market 'Levofloxacin', a generic used for ...